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Abstract
In rheumatoid arthritis (RA), a key event is infiltration of inflammatory immune cells into the synovial lining, possibly
aggravated by dysregulation of cellular adhesion molecules. Therefore, single nucleotide polymorphisms of 14 genes
involved in cellular adhesion processes (CAST, ITGA4, ITGB1, ITGB2, PECAM1, PTEN, PTPN11, PTPRC, PXN, SELE, SELP, SRC, TYK2,
and VCAM1) were analyzed for association with RA. Association analysis was performed consecutively in three European RA
family sample groups (Nfamilies = 407). Additionally, we investigated differential allelic expression, a possible functional
consequence of genetic variants. SELP (selectin P, CD62P) SNP-allele rs6136-T was associated with risk for RA in two RA
family sample groups as well as in global analysis of all three groups (ptotal = 0.003). This allele was also expressed
preferentially (p,1026) with a two- fold average increase in regulated samples. Differential expression is supported by data
from Genevar MuTHER (p1 = 0.004; p2 = 0.0177). Evidence for influence of rs6136 on transcription factor binding was also
found in silico and in public datasets reporting in vitro data. In summary, we found SELP rs6136-T to be associated with RA
and with increased expression of SELP mRNA. SELP is located on the surface of endothelial cells and crucial for recruitment,
adhesion, and migration of inflammatory cells into the joint. Genetically determined increased SELP expression levels might
thus be a novel additional risk factor for RA.
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Introduction
Rheumatoid Arthritis (RA) is a chronic inflammatory disease
with features of an autoimmune disease [1]. There is ample
evidence for genetic influences on RA and heritability is estimated
to be about 60% [2]. It is estimated that risk alleles identified up to
now explain about 17% of seropositive RA [3]. One hallmark of
RA pathogenesis is infiltration of synovial fluid by autoreactive
immune cells. These cells release inflammatory cytokines, immu-
noglobulins, and rheumatoid factor (RF). Macrophages ingest
these RF immune complexes and release additional cytokines (e.g.
IL1, IL6), leading to activation of the complement system and
release of more inflammatory mediators and cartilage degrading
enzymes. Macrophages as well as proliferating fibroblast-like cells
induce typical joint swelling and pannus formation in the inflamed
synovial membrane. This cycle of activation and infiltration of
inflammatory cells, release of inflammatory mediators and action
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of aggressive cartilage degrading enzymes finally causes destruc-
tion of cartilage and joints. Hence, in the pathogenesis of RA,
infiltration of inflammatory cells into the synovial lining plays an
important role and may be modulated by dysregulation of cellular
adhesion molecules [4,5]. Adhesion molecules are expressed on
the surface of cells and mediate adhesion of cells to other cells or to
the extracellular matrix [6]. They can be divided into three
superfamilies: selectins, integrins, and the Ig-superfamily. Adhe-
sion molecules regulate leukocyte circulation, lymphoid cell
homing to tissues and inflammatory sites, and transendothelial
migration. They also participate in lymphocyte co-stimulation,
cytotoxicity, lymphohemopoiesis, and B cell apoptosis. In RA,
gene expression of integrins and their ligands were found to be up-
regulated [7] and studies even suggest correlations with prognosis
and disease activity for adhesion gene products such as selectin P
which is encoded by the gene SELP [8,9]. Therefore, genes
involved in cellular adhesion processes are highly relevant
candidate genes for studying genetic association with RA.
To identify genes involved in cellular adhesion relevant in RA,
we performed a thorough literature and database analysis. We
favored genes that are located in genomic regions identified in
genome-wide linkage scans in RA families [10] and genes with
polymorphisms known to be associated with autoimmune disor-
ders. Table 1 displays relevant information on all 14 genes
selected. In brief, some properties and functions of these genes are
as follows: Integrin: Integrin ITGA4 is the alpha-4 subunit of
integrin VLA-4, ITGB1 is the beta-1 subunit of the same
molecule. VLA-4 is a cell surface receptor on activated lympho-
cytes and monocytes that binds the ligand VCAM1 on endothelial
cells. It is particularly involved in firm adhesion prior to migration.
ITGB2 is the beta-2 subunit of the integrin LFA-1, which is also
expressed on lymphocytes, especially leukocytes. Ligands of LFA-1
are ICAM1, ICAM2, and VCAM1 on endothelial cells. TYK2 is a
tyrosine kinase belonging to the group of Janus kinases. The
molecule is part of the regulatory network of integrin mediated
adhesion and migration by activating negative regulators upon
signaling [11]. The PXN (paxillin) gene is located in an RA
linkage region and part of the focal adhesion process. Its protein
product, PXN is in direct contact with the focal adhesion kinase
(FAK). PXN is part of growth factor and adhesion mediated cell
signaling processes including migration, proliferation, and gene
expression activation [12]. SRC is a kinase and part of the integrin
signaling network. Its gene is highly regulated by multiple binding
partners such as FAK. PTPRC is a binding partner and regulator
of SRC. During integrin mediated adhesion, PTPRC is bound to
the tyrosine kinase complex and inhibits SRC mainly via the
kinase domain [13]. There are several association studies
published for PTPRC with autoimmune diseases [14,15]. PTEN
and PTPN11 both are tumor suppressor genes involved in
migration processes. FAK is a substrate for PTEN and the FAK
pathway influences organization of actin filaments during cellular
migration [16]. PTPN11 is involved in Rho signaling, which is
part of cellular adhesion processes. It is also a positive regulator of
the SRC mediated integrin pathway [17]. Calpastatin (CAST) is
an inhibitor of calpain, a protease involved in apoptosis,
proliferation, and migration. This molecule is part of the
regulatory network of integrin mediated cellular adhesion via
RhoA and FAK signaling pathways as well as via direct binding to
the beta subunit of integrins,. Additionally, calpain regulates
integrin activation via talin, a prerequisite for firm adhesion.
Inhibition of calpain has been shown to reduce cellular migration
[18]. PECAM1 and VCAM1 belong to the Ig superfamily and are
widely expressed on hematopoietic cells. The blocking of
PECAM1 with specific antibodies reduces 90% of leukocyte
migration. In combination with CD99 blocking, diapedesis is
nearly completely inhibited [19]. SELE and SELP are adhesion
proteins belonging to the selectin class and are expressed on the
surface of activated endothelial cells. SELP (selectin P, CD62P)
can be activated immediately due to its location in Weibel-Palade
bodies, where it is stored along with von Willebrand factor. The
function of selectins is the binding of blood-leukocytes on activated
endothelial cells prior to migration in inflamed tissue and therefore
it is relevant for autoimmune diseases and RA in particular.
Circulating SELE is found to be increased in RA patients and
correlates with disease progression [20]. SELP is up-regulated in
atherosclerotic plaque and in patients with angina pectoris. The
non-synonymous single nucleotide polymorphisms (SNP) rs6136 in
SELP has previously been associated with myocardial infarction
with the A allele representing a risk factor [21,22]. RA patients
may also carry a higher risk for myocardial infarction [23].
Our aim was to investigate genetic variants in these 14 genes for
association with RA. We applied a multi-step approach, including
two consecutively genotyped French RA family trio sets for
discovery and replication. An additional set of 207 European RA
family trios was analyzed to assess broader applicability of detected
association effects in different populations. Overall, Nfamilies = 407
family trios were genotyped. Possible functional aspects of
identified associated SNPs were assessed by analysis of differential
allelic expression (DAE) and respective eQTLs (expression
quantitative trait loci). Losses and gains of possible transcription
factor binding sites (TFBS) due to presence of SNPs was analyzed
in silico and functional in vitro studies publicly available from the
ENCODE project were reviewed [24].
Materials and Methods
Gene and marker selection
We selected genes in cellular adhesion processes following a
thorough analysis of literature and databases at the time of
candidate selection. For this purpose we used MeSH (medical
subject headings) search terms in the PubMed database, available
information on biological pathways (e.g. KEGG pathways, http://
www.genome.jp/kegg/), gene ontology terms (http://www.
geneontology.org/), and genetic databases such as OMIM (Online
Mendelian Inheritance in Man, http://www.omim.org/), GDPinfo
(genomics and disease prevention information system, currently
accessible at http://hugenavigator.net/HuGENavigator/home.do),
and GAD (genetic association database, http://geneticassociationdb.
nih.gov/). Genes associated with autoimmunity and genes located in
genomic regions linked to RA in genome-wide linkage analysis
were preferred [10]. We note that our selection of genes must be
considered essentially subjective. It represents a subset of genes for
each of which a plausible link to cellular adhesion processes and to
immune diseases is given.
Haplotype structure of each gene was analyzed by Haploview
[25] and SNPs located in different LD (linkage disequilibrium) blocks
were selected. SNPs with previously published disease associations or
known functional consequences (e.g. non-synonymous coding SNPs)
if existent were preferred. Information on SNPs was retrieved from
databases EnsMart (http://www.ensembl.org/), PupaSNP [26],
UCSC (http://genome.ucsc.edu), HapMap (www.hapmap.org),
and dbSNP (http://www.ncbi.nlm.nih.gov/SNP/).
Probands
Three sets of family-trios, each trio comprising an RA patient
( = affected individual) and both parents, were genotyped. Detailed
characteristics of the first (French discovery set), second (French
replication set), and third (multinational European replicaton set)
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cohort are described elsewhere [27,28]. Briefly, the French
discovery and French replication set each consisted of 100 family
trios of French Caucasian origin with mostly similar characteris-
tics. The third set consisted of 207 additional European Caucasian
families, originating from France, Italy, Portugal, Spain, the
Netherlands, and Belgium. Table 2 displays clinical information
on all three cohorts as published previously [28]. All affected
individuals fulfilled the American College of Rheumatology 1987
revised criteria for RA [29].
Ethics Statement
All individuals provided written informed consent and the study
was approved by the Ethics Committee of Hoˆpital Kremlin-
Biceˆtre (Paris, France) according to the principles expressed in the
Declaration of Helsinki.
Analysis strategy and power calculation
In our multi-step approach all SNPs were genotyped in the first
sample set, the French discovery set. Markers with a significant
association with RA (uncorrected p value,0.05) were then
genotyped in the second sample set of the same homogeneous
population origin, the French replication set. As the replication set
was highly similar to the discovery set regarding ethnicity,
phenotyping procedure, and clinical characteristics, association
in the replication set can be considered a successful replication of
associations. When evidence increased in favor of an association,
i.e. the p-value of the association decreased in the combined
analysis of both sets, markers were genotyped in the third sample
set, the multinational European replication set. As the third set is
more heterogeneous due to its multiethnic origin, additional
association in set three can be considered informative for the
general relevance of an identified association.
For a marker with 35% minor allele frequency, we had 80%
power to identify a genotype relative risk of 1.66, 1.44, and 1.29
within 100, 200, and 407 trio families in the TDT test,
respectively. For a marker with 10% minor allele frequency, we
had the same power to identify a genotype relative risk of 2.06, 1.7,
and 1.47 within 100, 200, and 407 trio families in the TDT test,
respectively. Power calculation was done using the R add-on
package ‘‘powerpkg’’ using formula as described [30].
Extraction of DNA and RNA
Genomic DNA and/or RNA were purified from fresh
peripheral blood leukocytes or from Epstein-Barr virus (EBV)
transformed cell lines for differential allelic expression analysis
using standard methods.
Genotyping
Genotyping was carried out using the Genosnip technique by
Bruker Daltonics [31]. PCR primers were designed using MuPlex
Vs 2.2 [32]. Primer design for SBE (single base extension) was
carried out using PrimExtend, an in-house software tool based on
CalcDalton [33]. Primer-sequences are shown in Table S1.
Samples of the third set were genotyped by TaqMan 59 allelic
discrimination assays (Applied Biosystems, Foster City, CA, USA)
following manufacturer’s protocols. In quality control Mendel’s 1st
law of inheritance had to be fulfilled in at least 95% of all children.
Hardy-Weinberg Equilibrium (HWE) in non-transmitted controls
had not to be violated in a chi-square test with 1 degree of freedom
(p.0.01), all SNPs fulfilled these criteria. Non-transmitted controls
refer to a genotype comprising of the two alleles that were not
transmitted from the parents to the child. Individual-wise genotype
call-rate in any set of family trios was always at least 94%.
Association analysis
Linkage and association analyses were performed using the
Transmission Disequilibrium Test (TDT) [34]. The TDT
compares the transmission of SNP alleles from heterozygous
parents to affected offspring with a transmission ratio of 50% as
expected by Mendel’s 1st law. The allelic odds ratio (OR)
compares differences in genotype distribution between RA cases
and ‘virtual controls’ reconstructed from non-transmitted parental
alleles. For gene-wide haplotype analysis the software Haploview
4.1 was used [25].
Differential allelic expression (DAE) analysis
Complementary genomic DNA (gDNA) was derived from EBV
immortalized B cells of individual probands (N = 52) and screened
for individuals heterozygous for rs6136 applying Genosnip (see
genotyping for details and Table S1 for primers). Total RNA of
samples (N = 7) was extracted and reverse transcribed using standard
protocols. Three of these samples (tagged with prefix ‘‘RA’’) were
derived from RA patients, which was not the case for samples
termed 1–4. cDNA was genotyped applying Genosnip technology
similar to gDNA with PCR primers designed to span exons (for-
CTTCAGGACAATGGACAGCAGTA, rev-TCTTAGCAAAG-
CCAGGAGCG). Such primers make efficient co-amplification of
gDNA unlikely. Correct PCR product size was controlled by agarose
gel electrophoresis. For each cell line, three replicates were analyzed.
Each single replicate was quantified at least in triplicates applying
Genosnip and averaged. As the Genosnip method results in
quantitative signals for the genotyped alleles, data from genotyping
heterozygous cDNA can be used to quantify gene expression in an
Table 2. Characteristics of rheumatoid arthritis (RA) index cases from the investigated samples.
discovery set (N=100) replication set (N=100) multinational replication set 3 (N=207)
Population French Caucasian French Caucasian European Caucasian
Females (%) 87 90 86
Mean age of disease onset (y) 32 (610) 31 (66) 30 (69)
Mean disease duration (y) 18 (67) 16 (68) 8 (67)
patients with bone erosions (%) 90 79 70
RF+ patients (%) 81 76 73
Patients carrying .1 HLA-DRB1 shared
epitope allele (%)
78 80 Not available
N= number of families; RF+= rheumatoid factor positive.
doi:10.1371/journal.pone.0103872.t002
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allele specific manner. To identify DAE, the allelic ratio of
genotyped cDNA is compared with the allelic ratio found in gDNA,
which is expected to be around one. For robust quantification, signal
to noise ratios were used and the natural logarithm of the ratios was
calculated. We applied ANOVA to globally identify if allelic ratios
differed in cDNA from cell lines and gDNA (implemented in the
statistical software R (http://www.R-project.org) applying the R
add-on package ‘‘car’’). Then, we used Dunnett’s test to identify
‘‘regulated cell lines’’, i.e. cell lines where DAE is present. This was
defined to be the case when the allelic ratios of cDNA was
statistically significant different from the allelic ratios of gDNA
according to Dunnett’s test (applying the R add-on package
‘‘multcomp’’ [35]). In the context of this manuscript, ‘‘cis-
regulation’’ refers to DAE where regulated samples showed
increased expression of always the same allele [36]. This might
result from some direct mechanism which is not influenced much by
other aspects of the state of a cell.
For verification of DAE by an independent method, purified
PCR products (PCR-Purifying-Kit, Seqlab, Go¨ttingen, Germany)
originating from cDNA and genomic DNA of selected samples
were analyzed by eurofins-MWG/operon (Ebersberg, Germany)
with fluorescence-based sequencing (cycle sequencing technology
with dideoxy chain termination using an Applied Biosystems ABI
3730XL-sequencer). In this analysis, relative peak height in
sequencing traces was analyzed for evidence of DAE in an
analogous fashion.
eQTLs and gene expression analysis
Evidence for eQTL from public databases may be considered
corroborative evidence for DAE. Therefore, eQTLs were assessed
by comparing microarray expression data and genotyping data
available via Genevar database (Version 3.5.0). Specifically, we
used data from the pilot phase of The MuTHER Study [37]
measured in lymphoid, skin, and adipose tissues derived from
healthy female twin pairs.
Supplemental microarray gene expression data was accessed
through the Gene Expression Atlas 2.0.7.5 05/11 (http://www-
test.ebi.ac.uk/gxa/).
Evaluation of allele effects on transcription factor binding
sites
Genomatix SNPinspector software suite (v2.1, matrix library
8.3) was used to evaluate potential effects of SNP alleles on loss or
gain of potential transcription factor binding sites (TFBS). Two
scores, core similarity and matrix similarity, were analyzed. These
scores are based on similarities between the highest conserved
nucleotides of a predicted TFBS or a TFBS family matrix. Putative
gains or losses of TFBS were deemed relevant for scores .0.8
[38].
Additionally, we reviewed in vitro data on TFBS at the genomic
location of rs6136. Data are publicly available from the ENCODE
project and accessible via the UCSC genome browser [24].
Table 3. Results of genetic association analysis for rs754615 – CAST (minor allele C).
discovery set replication set joined discovery & replication set
# informative parents 98/200 87/200 185/400
minor allele transmission 61:37 42:41 103:78
Estimated Genotyping Accuracy (Mendel Errors) 100% (0) 100% (0) 100% (0)
TDT p-value 0.017 0.94 0.07
Minor allele frequency 34% 40% 37%
allelic OR (CI) 1.7 (1.1–2.5) 1.02 (0.7–1.6) 1.34 (1–1.8)
Shown are results in all samples in a given sample set; Minor allele transmissions (transmitted alleles/untransmitted alleles) are shown. Informative parents: Number of
parental individuals carrying a heterozygous genotype TDT: Transmission disequilibrium test considering informative parents, only. OR (CI) allelic odds ratio and 95%
confidence interval of the minor allele when considering all parents (transmitted vs. non-transmitted alleles). Minor allele frequency relates to controls (non-transmitted
alleles).
doi:10.1371/journal.pone.0103872.t003
Table 4. Results of genetic association analysis for rs6136 – SELP (minor allele G).
discovery set replication set
joined discovery &
replication set
multinational replication
set all sets combined
# informative parents 34/200 32/200 66/400 80/412 146/812
minor allele transmission 11:23 9:23 20:46 35:45 55:91
Estimated Genotyping
Accuracy (Mendel Errors)
100% (0) 99.1% (1) 99.6% (1) 100% (0) 99.8% (1)
TDT p-value 0.042 0.015 0.002 0.26 0.003
Minor allele frequency 13% 12% 13% 12% 12%
OR (CI) 0.54 (0.3–1.1) 0.38 (0.2–0.8) 0.47 (0.3–0.8) 0.77 (0.5–1.2) 0.62 (0.4–0.9)
Shown are results in all samples in a given sample set; Minor allele transmissions (transmitted alleles/untransmitted alleles) are shown. Informative parents: Number of
parental individuals carrying a heterozygous genotype TDT: Transmission disequilibrium test considering informative parents, only. OR (CI) allelic odds ratio and 95%
confidence interval of the minor allele when considering all parents (transmitted vs. non-transmitted alleles). Minor allele frequency relates to controls (non-transmitted
alleles).
doi:10.1371/journal.pone.0103872.t004
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Results
Association study
Of 14 selected genes comprising 43 SNPs, two SNPs in genes
SELP and CAST showed nominally significant association with
RA in the discovery set of French RA family trios (Table S2). We
also analyzed the association of gene-wide haplotypes in that
sample set, but did not find significant haplotype associations after
Bonferroni correction for the number of haplotypes found within
the gene. We then genotyped SNPs rs754615 (CAST, pTDT =
0.017) and rs6136 (SELP, pTDT = 0.042) in the replication set of
French RA family trios. CAST SNP rs754615 did not achieve
significance in the replication set alone (Table 3). In contrast, SNP
rs6136 was successfully replicated (pTDT = 0.015, Table 4). As the
direction of the association was the same in the discovery and
replication sets, association of SNP rs6136 with RA was even
stronger (pTDT = 0.002) when analyzed in joined data from both
sets. In consequence, SNP rs6136 qualified for genotyping in the
European RA family trio set for evaluation of broader relevance.
Here again rs6136 showed over-transmission of the major T-allele,
but significance was only reached if analyzed in combination with
the other two sets (pTDT = 0.003, Table 4). The power to detect
the association of rs6136 with RA as reported in Table 4 for all
sets combined was .95%. In subgroup analysis, the observed
association for rs6136 was stronger in females (OR 0.58; 95%CI
0.4–0.8) than in males (OR 0.9; 95%CI 0.4–2.2) and stronger in
patients with radiographic erosion (OR 0.71; 95%CI 0.4–1.4) than
in those without erosion (OR 0.9; 95%CI 0.4–2.2). However,
differences in odds ratios between subgroups were not statistically
significant (p.0.3).
Differential allelic expression
As SELP rs6136 was associated with RA in our multi-step RA
family trio study we analyzed SNP rs6136 for differential allelic
expression. We observed a cis-effect on expression levels of SELP
for rs6136 (ANOVA p,1026, figure 1). Dunnett’s test revealed
that three of the seven samples heterozygous for rs6136
individually showed significant DAE, always with the T-allele
Figure 1. Cis-directed DAE pattern of rs6136 in the SELP gene. Green boxplots indicate samples resulting from allele specific expression
analysis of cDNA. Samples tagged ‘‘RA’’ were derived from RA patients, which was not the case for samples 1–4; gDNA=allelic ratios of gDNA
samples which served as reference. SNR= signal to noise ratio. Stars indicate cDNA samples with increased expression of transcripts carrying variant
rs6136-T. ** = p-val,0.01, *** = p-value,0.001.
doi:10.1371/journal.pone.0103872.g001
Table 5. DAE pattern of SELP SNPs for selected samples.
SNP Sample
Allelic expression
ratio genotyping
Allelic expression
ratio sequencing p-val
rs6136
(T vs. G)
1 1.78 1.36 0.0037
RA2 2.51 6.18 ,0.001
RA3 1.12 1.65 0.97
Samples were measured with mass spectrometry-based genotyping and
fluorescence-based sequencing; p-values refer to data from genotyping and are
calculated by Dunnett’s test analyzing significant differences between allelic
fold changes between cDNA and gDNA.
doi:10.1371/journal.pone.0103872.t005
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being higher expressed than the C-allele. The average fold change
in regulated samples was 2. Direction of allelic expression fold
changes was verified by Sanger sequencing (Table 5).
To further evaluate our finding of overexpression of the rs6136-
T allele, we compared microarray expression data and genotype
data available via the Genevar database. Within data from the
pilot phase of The MuTHER Study [37] we observed a consistent
cis-eQTL with overexpression of the rs6136-T allele (SELP probe:
ILMN_1715417) in both (p1 = 0.004; p2 = 0.0177; figure 2). The
rs6136 variant was the strongest cis-eQTL hit within available
Genevar expression data in a region of at least 200 kbp up- and
downstream of SELP. For the closest neighbouring gene F5
(coagulating factor 5) no cis-eQTLs were detected.
The Genomatix SNPinspector software suite [38] was applied to
calculate possible gains or losses of transcription factor binding
sites (TFBS) for rs6136 and a SNP, rs9332575. SNP rs9332575 is
in perfect LD (D9= 1, r2 = 1) with exonic rs6136 within the
Caucasian HapMap population, but located 40 kbp upstream of it
(Table 6). The A-allele of rs9332575 corresponds to the T-allele of
rs6136. Higher similarity values predict higher probability of
transcription factor (TF) binding at this site. Table 6 shows several
identified possible losses or gains of TFBS for rs6136 and
rs9332575.
We also reviewed functional in vitro data on TF occupation
near rs6136. Such data is publicly available via the ENCODE
project [24]. For the genomic position of rs6136 we found an
NFKB TFBS with the highest possible score in an assay based on
chromatin immunoprecipitation (ChIP) followed by genome-wide
sequencing in lymphocytes. Additionally, the locus appeared to be
an open chromatin region as revealed through DNase I
hypersensitivity assay, indicating that the locus would be accessible
for TF.
Discussion
Adhesion molecules are potential candidate genes for involve-
ment in the complex immune disease Rheumatoid Arthritis. We
selected 14 genes involved in cellular adhesion processes and
investigated possible association with RA. Two of these genes,
CAST (encoding calpastatin) and SELP (encoding P selectin), were
associated with RA in our discovery set of French RA family trios.
Association of SNP rs6136 in SELP with RA could be successfully
independently replicated in our replication set of French family
trios and was still significant when including a larger European
Caucasian family trio cohort (pTotal = 0.003). Within all three sets,
the major T-allele was over-transmitted to RA patients in TDT,
which is robust against ethnic heterogeneity [39].
We compared our findings with data of a large meta-analysis of
genome-wide association studies (GWAS) for RA [40]. Although
rs6136 itself was not associated with RA (p = 0.86), several
nominal associations (p = 0.023 to p = 0.043) were found within
a range of +/275 kb of the SNP. However, LD was rather low
with those markers (R2,0.1). As association of rs6136 within our
Table 6. Possible losses or gains of transcription factor binding sites for rs6136 and rs9332575.
SNP alleles loss/gain TF family/gene TF name Core sim. Matrix sim.
rs6136 TRG loss HNF1/HMBOX Homeobox containing 1 0.77 0.831
rs6136 TRG gain SNAP/PSE Proximal sequence element 0.967 0.756
rs6136 TRG gain E2FF/E2F E2F transcription factor 1 0.785 0.852
rs9332575 ARG loss GATA globin transcription factor 1 1 0.938
rs9332575 ARG loss HNF1 Hepatocyte nuclear factor 1 alpha 1 0.841
rs9332575 ARG loss EVI1 Ecotropic viral integration site 1
encoded factor
0.75 0.819
rs9332575 ARG gain ZFHX/AREB6 Atp 1a1 regulatory element binding
factor 6
1 0.984
Prediction of altered transcription factor binding sites due to alleles of rs6136 and rs9332575. rs9332575 is a neighboring variant for rs6136 which is in perfect linkage
disequilibrium. Core sim.: score for highest conserved nucleotides of a known TFBS. Matrix sim.: score for highest conserved nucleotides of a known TFBS family matrix.
Similarity scores .0.8 indicate relevant predictions [38].
doi:10.1371/journal.pone.0103872.t006
Figure 2. Cis-eQTL for rs6136 in the SELP gene in skin tissue from two sets of twins. Data were derived from The MuTHER Study [37] and
analyzed by applying Genevar 3.5.0. These data successfully replicated DAE for rs6136. The two diagrams represent results from two skin sample
groups derived from 76 and 84 female twins.
doi:10.1371/journal.pone.0103872.g002
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European Caucasian family trio cohort alone showed the same
direction but did not reach significance, SELP-rs6136 might be of
specific relevance in subgroups of RA patients with characteristics
similar to our French discovery and replication cohorts. In
particular, these two patient cohorts are known to be enriched for
early onset RA and more severe phenotypes [41]. This should be
considered when planning replication of the association of rs6136
in additional populations in addition to the power issues resulting
from the relatively low minor allele frequency of rs6136 (Table 2).
We investigated SNP rs6136 for preferential expression of one
of its alleles. Indeed, we observed preferential overexpression of
the rs6136-T allele in three samples with an average fold change of
2.0 in regulated samples. Note, that there is a very high probability
that DAE identified in at least three heterozygous individuals
represents a true biological phenomenon [42]. However, not all
samples heterozygous for rs6136 showed DAE, some appeared
unregulated. This might indicate that in addition to the rs6136-T
allele additional factors are necessary for upregulated SELP
expression. Sampling effects might also offer an explanation.
Alternatively, a SNP in non-perfect LD with rs6136 may be the
true causative variant. However, we did not find any other
polymorphism in or near the SELP gene which correlates with
SELP expression more strongly than rs6136, even when account-
ing for common haplotype tagging SNPs. Interestingly, the highest
differential expression was found in a cell line from an RA patient.
However, overall, the pattern of DAE appeared to be rather
similar between RA patients and non-RA patients (figure 1).
Upregulation of SELP expression for carriers of rs6136-T was
successfully replicated using data of The MuTHER Study [37]
(figure 2). An association between rs6136 and SELP protein levels
was also reported by the CHARGE consortium [43]. As this data
is from different tissue and from different populations, this might
hint at a general relevance of rs6136-T for increased gene
expression of SELP.
Several TFBS were predicted to be changed either by variants
of rs6136 or rs9332575, the latter a SNP in perfect linkage
disequilibrium with rs6136. The highest scored (similarity score)
loss of a TFBS was that of a GATA1 binding site for rs9332575
and the highest scored gain that of AREB6. While no RA relevant
function is known for AREB6, GATA1 (globin transcription factor
1) plays a role in erythroid development and differentiation, but is
also expressed in various cells, especially of hematopoietic lineage.
GATA1 is reported to play a role in maturation of dendritic cells,
an antigen presenting cell population able to activate naı¨ve T cells
during immune response [44].
We also found an NFKB TFBS by reviewing ENCODE in vitro
data originally acquired by ChIP followed by genome-wide
sequencing. An open chromatin structure at the site of rs6136
was found, indicating accessibility for TF binding. As NFKB is a
TF predominantly activated during inflammatory processes and
found to be especially relevant for RA pathology, NFKB might
also be involved in increased selectin P expression levels in
genetically predestined patients [45].
Within the Gene Expression Atlas (experiment E-GEOD-7307),
SELP mRNA expression was found increased in two tissues most
relevant for RA pathogenesis: joint synovium (p = 0.007, N = 3)
and synovial membrane (p = 4610210, N = 11) (figure 3). SELP
expression was also increased in RA patients (p = 0.033, N = 5) and
in a rat model of pristane induced arthritis (experiment E-MEXP-
782) (p = 0.047). Functional studies focusing on cis-regulation of
SELP expression would be required to further corroborate our
findings and possibly reveal the mechanism and consequences of
SELP DAE.
The relevance of SELP in RA and other diseases is underlined
by the finding of increased soluble SELP levels for many diseases,
including atherosclerosis, in which soluble SELP is derived mostly
from endothelial cells [44], and RA [46]. RA shows considerable
comorbidity with cardiovascular diseases [23]. Soluble SELP
correlates with RA disease activity [9,47] and lower SELP levels
are found during RA remission [48]. High levels of soluble SELP
are predictive of future cardiovascular events [49–51]. Supporting
this, Lee et al. reported SNP rs6136 being linked to high serum
SELP levels within the Framingham Heart Study [52]. After
adjustment for clinical factors such as hormone therapy, about
10% of altered SELP concentration in serum of participants is
explained by the rs6136 variant. Individuals carrying the TT
genotype display about double the SELP concentrations compared
to individuals carrying the GG variant. These findings corroborate
our own findings that rs6136 may be a functional SNP.
SELP is essential for recruitment, adhesion and migration of
inflammatory cells into joint tissue and synovial membrane.
Blocking of SELP expression with specific antibodies resulted in
blocked adhesion [53], as well as reduced neutrophil recruitment
[54]. In a SELP deficient mouse model of antigen-induced
arthritis leukocyte-endothelial cell interaction was decreased [55].
Additionally, a chemical compound acting as SELP antagonist
efficiently reduced inflammation in the rat adjuvant induced
arthritis model [56].
The RA-associated major T-allele of rs6136 was linked to
increased SELP expression. As a possible mechanism, we suggest
that increased SELP expression might promote the increased
recruitment of leukocytes to a site of inflamed tissue such as the
synovial lining in RA. Subsequently, the inflammation may be
prolonged or elevated, which might influence disease activity and
severity. These processes related to SELP expression should be
studied in more detail in the future.
In summary, we found SELP rs6136-T to be associated with
RA and with increased expression of SELP mRNA. Genetically
determined increased SELP expression levels might thus be a
novel additional risk factor for RA.
Supporting Information
Table S1 PCR and SBE Primer for Genotyping of
adhesion genes. PCR primer designed with MuPlex 2.2, SBE
Figure 3. SELP expression profiles for human RA compared to
healthy tissue and pristane induced arthritis in rat. Data derived
from Gene Expression Atlas (E-GEOD-7307). Nnormal = 679 (including
healthy joint synovium and synovial membrane samples), NRA = 5, Njoint
synovium = 3 (all healthy), Nsynovial membrane = 11 (Nnormal = 6, NRA = 5). Nrats-
untreated = 5, Nrats+pristane = 5.
doi:10.1371/journal.pone.0103872.g003
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Table S2 Results of Genotyping in French RA family
trio set 1.
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